# Collaborative Efforts in Pediatric Surgery: Lessons from European Randomized Controlled Trials

## TL;DR

This paper discusses challenges and lessons learned from European pediatric surgery trials for rare conditions, emphasizing collaboration and adaptability.

## Contribution

The paper provides practical insights and strategies for conducting multicenter RCTs in rare pediatric surgical conditions.

## Key findings

- Multidisciplinary collaboration and existing research networks are crucial for trial success.
- Adaptive protocols and stakeholder engagement help overcome recruitment and regulatory challenges.
- The pandemic highlighted the need for flexible and patient-centered trial designs.

## Abstract

Conducting multicenter randomized controlled trials (RCTs) in pediatric surgery for rare congenital anomalies presents unique challenges, including low patient recruitment, complex regulatory landscapes, and variability in care standards. This paper reflects on the experiences and lessons learned from the MUC-FIRE and STEPS-EA trials, supported by the European Reference Network for Rare Inherited and Congenital Anomalies (ERNICA), to provide guidance for future studies.

A retrospective review was conducted on the design and execution of these trials, focusing on team composition, endpoint selection, patient recruitment strategies, regulatory compliance, and adaptive methodologies. Insights were derived from study protocols, monitoring reports, and the authors' experiences.

Key factors contributing to trial success included multidisciplinary collaboration, leveraging existing research networks, and defining clear, measurable endpoints. Challenges such as recruitment delays, regulatory hurdles, and variations in care were mitigated through flexible protocols, proactive amendments, and stakeholder engagement. The COVID-19 pandemic amplified these difficulties, necessitating innovative strategies and extended timelines.

The MUC-FIRE and STEPS-EA trials underscore the critical importance of international collaboration, adaptive strategies, and patient-centered approaches in overcoming the complexities of multicenter RCTs. Lessons from these experiences can inform the design and implementation of future trials, ultimately enhancing evidence generation and improving outcomes for children with rare congenital anomalies.